BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1154 related articles for article (PubMed ID: 31957833)

  • 21. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
    Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
    Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
    [No Abstract]   [Full Text] [Related]  

  • 23. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
    Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA potassium voltage-gated channel subfamily Q member 1 overlapping transcript 1 regulates the proliferation and osteogenic differentiation of human periodontal ligament stem cells by targeting miR-24-3p.
    Pang M; Wei HX; Chen X
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Oct; 39(5):547-554. PubMed ID: 34636202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells.
    Zhang X; Dai X; Zhao X; Wang J; Dou J; Zhuang H; Chen N; Zhao H
    Bioengineered; 2022 Mar; 13(3):7082-7104. PubMed ID: 35282764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
    Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
    Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosomal lncRNA HEIH promotes cisplatin resistance in tongue squamous cell carcinoma via targeting miR-3619-5p/HDGF axis.
    Wang X; Yu H; Yu Z; Wang D
    Acta Histochem; 2020 Dec; 122(8):151647. PubMed ID: 33130420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA circ-RNF121 contributes to cisplatin (DDP) resistance of non-small-cell lung cancer cells by regulating the miR-646/SOX4 axis.
    Liu Y; Zhai R; Hu S; Liu J
    Anticancer Drugs; 2022 Jan; 33(1):e186-e197. PubMed ID: 34387608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. lncRNA KCNQ1OT1 promotes the proliferation, migration and invasion of retinoblastoma cells by upregulating HIF-1α via sponging miR-153-3p.
    Wang Y; Wang J; Hao H; Luo X
    J Investig Med; 2020 Dec; 68(8):1349-1356. PubMed ID: 33051357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA KCNQ1OT1 inhibits the radiosensitivity and promotes the tumorigenesis of hepatocellular carcinoma via the miR-146a-5p/ACER3 axis.
    Yang G; Zhou L; Xu Q; Meng F; Wan Y; Meng X; Wang L; Zhang L
    Cell Cycle; 2020 Oct; 19(19):2519-2529. PubMed ID: 32936716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA KCNQ1OT1 is a key factor in the reversal effect of curcumin on cisplatin resistance in the colorectal cancer cells.
    Zheng ZH; You HY; Feng YJ; Zhang ZT
    Mol Cell Biochem; 2021 Jul; 476(7):2575-2585. PubMed ID: 32757174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of cir_RNA PVT1 Elevates Gastric Cancer Cisplatin Sensitivity via Sponging miR-152-3p.
    Wang X; Zhang Y; Li W; Liu X
    J Surg Res; 2021 May; 261():185-195. PubMed ID: 33444948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA KCNQ1OT1 promotes proliferation, migration and invasion via targeting miR-134 in retinoblastoma.
    Wang L; Yi S; Wang R; Wang J
    J Gene Med; 2021 Jun; 23(6):e3336. PubMed ID: 33818859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
    Xiao XH; He SY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Regulatory relationship between lncRNA KCNQ1OT1 and miR-146a-3p in preeclampsia].
    Chen FR; Zheng LM; Wu DC; Gong HM; Cen H; Chen WC
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):535-543. PubMed ID: 32854478
    [No Abstract]   [Full Text] [Related]  

  • 36. Circular RNA circ_0048764 promotes the development of breast cancer by regulating microRNA-1296-5p/tripartite motif containing 14 axis.
    Xie F; Xiong Y; Yan J; Wang L; Yan W
    Bioengineered; 2022 Feb; 13(2):1963-1974. PubMed ID: 34787066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circ_0004104 knockdown alleviates oxidized low-density lipoprotein-induced dysfunction in vascular endothelial cells through targeting miR-328-3p/TRIM14 axis in atherosclerosis.
    Zhang C; Wang L; Shen Y
    BMC Cardiovasc Disord; 2021 Apr; 21(1):207. PubMed ID: 33892646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA miR-29c-3p modulates FOS expression to repress EMT and cell proliferation while induces apoptosis in TGF-β2-treated lens epithelial cells regulated by lncRNA KCNQ1OT1.
    Yao L; Yang L; Song H; Liu T; Yan H
    Biomed Pharmacother; 2020 Sep; 129():110290. PubMed ID: 32534225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
    Sun J; Min H; Yu L; Yu G; Shi Y; Sun J
    Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4.
    Hu B; Zhang H; Wang Z; Zhang F; Wei H; Li L
    Cancer Biol Ther; 2017 Dec; 18(12):974-983. PubMed ID: 29020498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.